Immunology

PROGRAM TARGET DISCOVERY PRECLINICAL / IND
ENABLING
Phase 1
ATTO-1310 IL31

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque in dignissim dolor. Sed a ornare augue. Fusce tincidunt ut tellus et fermentum.
ATTO-002 IL31 X IL13

ATTO-004 GPCR

ATTO-005 Cytokine X + Cytokine Y (IBD)

Oncology

PROGRAM TARGET DISCOVERY PRECLINICAL / IND
ENABLING
Phase 1
ATTO-003 B7H4

Therapeutic Area

PROGRAM TARGET DISCOVERY PRECLINICAL / IND
ENABLING
Phase 1
ATTO-003 B7H4